Literature DB >> 2830035

On the daily variation in the beta-receptor-adenylate cyclase-cAMP-phosphodiesterase system in rat forebrain.

B Lemmer1, H Bärmeier, S Schmidt, P H Lang.   

Abstract

In rat forebrain tissue of single rats beta-adrenoceptor density (Bmax) and affinity (Kd) were determined by saturation isotherms in receptor binding studies with the antagonist ligand (3H)-dihydroalprenolol at 8 different times of day in May. Rats were on a controlled 12L:12D photoperiod. In addition, the cAMP content, the formation of cAMP from ATP by the adenylate cyclase and the hydrolysis of the second messenger by the phosphodiesterase were determined at the same time points. No significant (ANOVA) daily variations were found in the total number of 3H-DHA binding sites (Bmax) nor in the affinity (Kd). In contrast, basal cAMP content as well as basal formation and hydrolysis of cAMP displayed significant rhythms. The peak value in cAMP was at the beginning of light. At that time the daily trough value in cAMP formation was found. Hydrolysis of cAMP by the phosphodiesterase displayed a 12-hr rhythm with trough values occurring at the early light and early dark period. The results demonstrate pronounced rhythmic changes in basal formation, content and hydrolysis of cAMP which are, however, not paralleled by changes in receptor number and/or affinity in the same tissue.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2830035     DOI: 10.3109/07420528709078537

Source DB:  PubMed          Journal:  Chronobiol Int        ISSN: 0742-0528            Impact factor:   2.877


  2 in total

1.  Clinical chronopharmacology of oral sustained-release isosorbide-5-mononitrate in healthy subjects.

Authors:  B Lemmer; B Scheidel; H Blume; H J Becker
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

2.  Circadian rhythm in the response of central 5-HT1A receptors to 8-OH-DPAT in rats.

Authors:  J Q Lu; H Nagayama
Journal:  Psychopharmacology (Berl)       Date:  1996-01       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.